Synthesis and pharmacological characterization of [125I]MRS1898, a high-affinity, selective radioligand for the rat A3 adenosine receptor

Purinergic Signalling

Volumn 5, Issue 1, 2009, Pages 31-37

  Gao, Zhan Guo ^a   Teng, Bao ^b   Wu, Haitao ^b   Joshi, Bhalchandra V ^a,c   Griffiths, Gary L ^b   Jacobson, Kenneth A ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NEKTAR THERAPEUTICS   (United States)

Author keywords

Binding assay; Carbocyclic; G protein coupled receptor; Iodination; Nucleoside; Purine

Indexed keywords

EID: 60449085494     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-008-9107-1     Document Type: Article

References (21)

1. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527-552
2. Baraldi PG, Cacciari B, Romagnoli R, Merighi S, Varani K, Borea PA, Spalluto G (2000) Adenosine Receptor Ligands: History and Perspectives. Med Res Rev 20:103-128
3. Jacobson KA, Gao ZG (2006) Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 5:247-264
4. Müller CE (2000) Adenosine receptor ligands-recent developments part I. Agonists. Curr Med Chem 7:1269-1288
5. Gao ZG, Jacobson KA (2007) Emerging adenosine receptor agonists. Expert Opin Emerg Drugs 12:479-492
6. 3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition. Clin Cancer Res 10:4472-4479
7. 3 adenosine subtype. J Cell Physiol 211:826-836
8. 3 adenosine receptor. Mol Pharmacol 45:978-982
9. 3 adenosine receptors in human tumor cell lines. Curr Med Chem 12:1319-1329
10. 3 receptor ligands. Curr Top Med Chem 3:445-462
11. Klotz KN, Hessling J, Hegler J, Owman C, Kull B, Fredholm BB, Lohse MJ (1998) Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol 357:1-9
12. 3 receptor. Eur J Pharmacol 556:14-18
13. 3 adenosine receptor in peripheral blood mononuclear cells in rheumatoid arthritis: Involvement of nuclear factor-kappaB in mediating receptor level. J Rheumatol 34:20-26
14. 3 adenosine receptors. Biochem Pharmacol 65:1675-1684
15. 3 adenosine receptor. J Med Chem 50:1222-1230
16. Jacobson KA, Ji X-d, Li AH, Melman N, Siddiqui MA, Shin KJ, Marquez VE, Ravi RG (2000) Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists. J Med Chem 43:2196-2203
17. Lee K, Ravi RG, Ji X-d, Marquez VE, Jacobson KA (2001) Ring-constrained (N)methanocarba-nucleosides as adenosine receptor agonists: Independent 5¢-uronamide and 2¢-deoxy modifications. Bioorg Med Chem Lett 11:1333-1337
18. 3 adenosine receptor agonists. J Med Chem 48:1745-1758
19. Vaidyanathan G, Zalutsky MR (2006) Preparation of N-succinimidyl 3-[*I]iodobenzoate: An agent for the indirect radioiodination of proteins. Nat Protocols 1:707-713
20. Cheng Y-C, Prusoff WH (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108
21. 3 adenosine receptor. Proc Natl Acad Sci USA 89:7432-7436